Trial Profile
A phase II study of NK105 for patients with previously treated advanced or recurrent gastric cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 May 2016
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Sponsors Nippon Kayaku
- 24 May 2016 New trial record